Magna Concursos

Foram encontradas 240 questões.

Read the paragraph below to answer question.
The alarm Europe the discovery horse meat beef products escalated again Monday, when the Swedish furniture giant Ikea withdrew an estimated 1,670 pounds meatballs sale 14 European countries. Ikea acted after authorities in the Czech Republic detected horse meat in its meatballs. The company said it had made the decision even though its tests two weeks ago did not detect horse DNA. Horse meat mixed with beef was first found last month in Ireland, then Britain, and has now expanded steadily across the Continent. The situation in Europe has created unease among American consumers over or not horse meat might also find its way into the food supply in the United States.
(The New York Times, 2/25/2013)
According to the formal rule of the English language, choose the alternative that fills in correctly the blank of the sentence below.
“The situation in Europe has created unease among American consumers over or not horse meat might also find its way into the food supply in the United States”.
 

Provas

Questão presente nas seguintes provas
Read the paragraph below to answer question.
The alarm Europe the discovery horse meat beef products escalated again Monday, when the Swedish furniture giant Ikea withdrew an estimated 1,670 pounds meatballs sale 14 European countries. Ikea acted after authorities in the Czech Republic detected horse meat in its meatballs. The company said it had made the decision even though its tests two weeks ago did not detect horse DNA. Horse meat mixed with beef was first found last month in Ireland, then Britain, and has now expanded steadily across the Continent. The situation in Europe has created unease among American consumers over or not horse meat might also find its way into the food supply in the United States.
(The New York Times, 2/25/2013)
Choose the alternative that fills in, correctly and respectively, the blanks of the sentence below.
“The alarm Europe the discovery horse meat beef products escalated again Monday, when the Swedish furniture giant Ikea withdrew an estimated 1,670 pounds meatballs sale 14 European countries”.
 

Provas

Questão presente nas seguintes provas
Read the text below to answer question.
FDA seems to take light approach to Allergan and LAP-BAND
In 1960, a young inspector for the Food and Drug Administration faced down a powerful drug company by rejecting its application to sell a morning-sickness drug in the United States. The company, Richardson-Merrell, griped about her repeated demands for more safety data. They complained to her superiors, branding her as a nitpicker. But she stood firm. The drug in question was thalidomide, and worldwide as many as 12,000 children were born with severe birth defects after their mothers used it. In the U.S., where Frances Kelsey blocked Merrell from distributing the drug except to a few doctors for "experimental" trials, the toll was 17. Today’s FDA isn’t that FDA.
Today's FDA can be steamrollered. Today's FDA just approved an application by Allergan to expand the target market of its Lap-Band weight-loss device potentially by tens of millions of patients. How much safety data did the FDA review before giving Allergan the green light? Mainly the results of one year of study of 149 patients. Kelsey has said that she demanded more information from Merrell, thalidomide's U.S. manufacturer, because its history of conflicts with the agency made her suspicious. Is there any reason to mistrust Allergan? Let's look at the record. In September, Allergan pleaded guilty to one criminal count and paid $600 million in fines and penalties to settle federal charges that it had illegally marketed Botox for uses the FDA hadn't approved. In accepting the plea bargain, the government charged that the company had made under-thetable payments to doctors who used Botox to treat unapproved conditions, created front groups and websites to push the broader uses of the drug while concealing Allergan's backing, and coached physicians to over-diagnose a condition for which Botox could be legally marketed so it could sell more product. Allergan took these steps, the government contended, because the approved uses had meager sales potential. The most prevalent condition for which Botox treatment was approved, cervical dystonia, is a neck spasm that affects only about 27,000 people. Allergan wanted doctors to prescribe Botox for headaches. Botox's sales grew 1,407% and by 2007, total Botox sales exceeded $500 million. More than 70% of that was for unapproved uses.
This didn't seem to enter into the FDA's review of Allergan's application to expand its marketing of the Lap-Band, a device that's surgically implanted around the stomach. So far, the approved use has been for morbidly obese people. An FDA advisory panel, which gave preliminary approval to Allergan's application, wasn't entirely happy with the company's data supporting its safety and efficacy claims for the Lap-Band — its own 149-patient study and six other studies, at least three of which conducted by researchers with financial links to Allergan — but they felt that the Lap-Band's benefits outweighed the risks.
(HILTZIKLOS, M., Adapted from Los Angeles Times, 22/02/2011)
Read the sentence below
“Botox's sales grew 1,407% and by 2007, total Botox sales exceeded $500 million. More than 70% of that was for unapproved uses.”
It is correct to affirm that the underlined word refers to
 

Provas

Questão presente nas seguintes provas
Read the text below to answer question.
FDA seems to take light approach to Allergan and LAP-BAND
In 1960, a young inspector for the Food and Drug Administration faced down a powerful drug company by rejecting its application to sell a morning-sickness drug in the United States. The company, Richardson-Merrell, griped about her repeated demands for more safety data. They complained to her superiors, branding her as a nitpicker. But she stood firm. The drug in question was thalidomide, and worldwide as many as 12,000 children were born with severe birth defects after their mothers used it. In the U.S., where Frances Kelsey blocked Merrell from distributing the drug except to a few doctors for "experimental" trials, the toll was 17. Today’s FDA isn’t that FDA.
Today's FDA can be steamrollered. Today's FDA just approved an application by Allergan to expand the target market of its Lap-Band weight-loss device potentially by tens of millions of patients. How much safety data did the FDA review before giving Allergan the green light? Mainly the results of one year of study of 149 patients. Kelsey has said that she demanded more information from Merrell, thalidomide's U.S. manufacturer, because its history of conflicts with the agency made her suspicious. Is there any reason to mistrust Allergan? Let's look at the record. In September, Allergan pleaded guilty to one criminal count and paid $600 million in fines and penalties to settle federal charges that it had illegally marketed Botox for uses the FDA hadn't approved. In accepting the plea bargain, the government charged that the company had made under-thetable payments to doctors who used Botox to treat unapproved conditions, created front groups and websites to push the broader uses of the drug while concealing Allergan's backing, and coached physicians to over-diagnose a condition for which Botox could be legally marketed so it could sell more product. Allergan took these steps, the government contended, because the approved uses had meager sales potential. The most prevalent condition for which Botox treatment was approved, cervical dystonia, is a neck spasm that affects only about 27,000 people. Allergan wanted doctors to prescribe Botox for headaches. Botox's sales grew 1,407% and by 2007, total Botox sales exceeded $500 million. More than 70% of that was for unapproved uses.
This didn't seem to enter into the FDA's review of Allergan's application to expand its marketing of the Lap-Band, a device that's surgically implanted around the stomach. So far, the approved use has been for morbidly obese people. An FDA advisory panel, which gave preliminary approval to Allergan's application, wasn't entirely happy with the company's data supporting its safety and efficacy claims for the Lap-Band — its own 149-patient study and six other studies, at least three of which conducted by researchers with financial links to Allergan — but they felt that the Lap-Band's benefits outweighed the risks.
(HILTZIKLOS, M., Adapted from Los Angeles Times, 22/02/2011)
Read the sentence below and choose the alternative that correctly links the underlined words to the nouns they refer to.
An FDA advisory panel, (I)which gave preliminary approval to Allergan's application, wasn't entirely happy with the company's data supporting (II)its safety and efficacy claims for the Lap-Band— (III)its own 149-patient study and six other studies, at least three of (IV)which conducted by researchers with financial links to Allergan.
 

Provas

Questão presente nas seguintes provas
Read the text below to answer question.
FDA seems to take light approach to Allergan and LAP-BAND
In 1960, a young inspector for the Food and Drug Administration faced down a powerful drug company by rejecting its application to sell a morning-sickness drug in the United States. The company, Richardson-Merrell, griped about her repeated demands for more safety data. They complained to her superiors, branding her as a nitpicker. But she stood firm. The drug in question was thalidomide, and worldwide as many as 12,000 children were born with severe birth defects after their mothers used it. In the U.S., where Frances Kelsey blocked Merrell from distributing the drug except to a few doctors for "experimental" trials, the toll was 17. Today’s FDA isn’t that FDA.
Today's FDA can be steamrollered. Today's FDA just approved an application by Allergan to expand the target market of its Lap-Band weight-loss device potentially by tens of millions of patients. How much safety data did the FDA review before giving Allergan the green light? Mainly the results of one year of study of 149 patients. Kelsey has said that she demanded more information from Merrell, thalidomide's U.S. manufacturer, because its history of conflicts with the agency made her suspicious. Is there any reason to mistrust Allergan? Let's look at the record. In September, Allergan pleaded guilty to one criminal count and paid $600 million in fines and penalties to settle federal charges that it had illegally marketed Botox for uses the FDA hadn't approved. In accepting the plea bargain, the government charged that the company had made under-thetable payments to doctors who used Botox to treat unapproved conditions, created front groups and websites to push the broader uses of the drug while concealing Allergan's backing, and coached physicians to over-diagnose a condition for which Botox could be legally marketed so it could sell more product. Allergan took these steps, the government contended, because the approved uses had meager sales potential. The most prevalent condition for which Botox treatment was approved, cervical dystonia, is a neck spasm that affects only about 27,000 people. Allergan wanted doctors to prescribe Botox for headaches. Botox's sales grew 1,407% and by 2007, total Botox sales exceeded $500 million. More than 70% of that was for unapproved uses.
This didn't seem to enter into the FDA's review of Allergan's application to expand its marketing of the Lap-Band, a device that's surgically implanted around the stomach. So far, the approved use has been for morbidly obese people. An FDA advisory panel, which gave preliminary approval to Allergan's application, wasn't entirely happy with the company's data supporting its safety and efficacy claims for the Lap-Band — its own 149-patient study and six other studies, at least three of which conducted by researchers with financial links to Allergan — but they felt that the Lap-Band's benefits outweighed the risks.
(HILTZIKLOS, M., Adapted from Los Angeles Times, 22/02/2011)
Read the sentence below.
“Today's FDA can be steamrollered.”
Choose the alternative that presents the best synonymous to the underlined verb.
 

Provas

Questão presente nas seguintes provas
Read the text below to answer question.
FDA seems to take light approach to Allergan and LAP-BAND
In 1960, a young inspector for the Food and Drug Administration faced down a powerful drug company by rejecting its application to sell a morning-sickness drug in the United States. The company, Richardson-Merrell, griped about her repeated demands for more safety data. They complained to her superiors, branding her as a nitpicker. But she stood firm. The drug in question was thalidomide, and worldwide as many as 12,000 children were born with severe birth defects after their mothers used it. In the U.S., where Frances Kelsey blocked Merrell from distributing the drug except to a few doctors for "experimental" trials, the toll was 17. Today’s FDA isn’t that FDA.
Today's FDA can be steamrollered. Today's FDA just approved an application by Allergan to expand the target market of its Lap-Band weight-loss device potentially by tens of millions of patients. How much safety data did the FDA review before giving Allergan the green light? Mainly the results of one year of study of 149 patients. Kelsey has said that she demanded more information from Merrell, thalidomide's U.S. manufacturer, because its history of conflicts with the agency made her suspicious. Is there any reason to mistrust Allergan? Let's look at the record. In September, Allergan pleaded guilty to one criminal count and paid $600 million in fines and penalties to settle federal charges that it had illegally marketed Botox for uses the FDA hadn't approved. In accepting the plea bargain, the government charged that the company had made under-thetable payments to doctors who used Botox to treat unapproved conditions, created front groups and websites to push the broader uses of the drug while concealing Allergan's backing, and coached physicians to over-diagnose a condition for which Botox could be legally marketed so it could sell more product. Allergan took these steps, the government contended, because the approved uses had meager sales potential. The most prevalent condition for which Botox treatment was approved, cervical dystonia, is a neck spasm that affects only about 27,000 people. Allergan wanted doctors to prescribe Botox for headaches. Botox's sales grew 1,407% and by 2007, total Botox sales exceeded $500 million. More than 70% of that was for unapproved uses.
This didn't seem to enter into the FDA's review of Allergan's application to expand its marketing of the Lap-Band, a device that's surgically implanted around the stomach. So far, the approved use has been for morbidly obese people. An FDA advisory panel, which gave preliminary approval to Allergan's application, wasn't entirely happy with the company's data supporting its safety and efficacy claims for the Lap-Band — its own 149-patient study and six other studies, at least three of which conducted by researchers with financial links to Allergan — but they felt that the Lap-Band's benefits outweighed the risks.
(HILTZIKLOS, M., Adapted from Los Angeles Times, 22/02/2011)
According to the text, it is correct to afirm that
 

Provas

Questão presente nas seguintes provas
Read the text below to answer question.
FDA seems to take light approach to Allergan and LAP-BAND
In 1960, a young inspector for the Food and Drug Administration faced down a powerful drug company by rejecting its application to sell a morning-sickness drug in the United States. The company, Richardson-Merrell, griped about her repeated demands for more safety data. They complained to her superiors, branding her as a nitpicker. But she stood firm. The drug in question was thalidomide, and worldwide as many as 12,000 children were born with severe birth defects after their mothers used it. In the U.S., where Frances Kelsey blocked Merrell from distributing the drug except to a few doctors for "experimental" trials, the toll was 17. Today’s FDA isn’t that FDA.
Today's FDA can be steamrollered. Today's FDA just approved an application by Allergan to expand the target market of its Lap-Band weight-loss device potentially by tens of millions of patients. How much safety data did the FDA review before giving Allergan the green light? Mainly the results of one year of study of 149 patients. Kelsey has said that she demanded more information from Merrell, thalidomide's U.S. manufacturer, because its history of conflicts with the agency made her suspicious. Is there any reason to mistrust Allergan? Let's look at the record. In September, Allergan pleaded guilty to one criminal count and paid $600 million in fines and penalties to settle federal charges that it had illegally marketed Botox for uses the FDA hadn't approved. In accepting the plea bargain, the government charged that the company had made under-thetable payments to doctors who used Botox to treat unapproved conditions, created front groups and websites to push the broader uses of the drug while concealing Allergan's backing, and coached physicians to over-diagnose a condition for which Botox could be legally marketed so it could sell more product. Allergan took these steps, the government contended, because the approved uses had meager sales potential. The most prevalent condition for which Botox treatment was approved, cervical dystonia, is a neck spasm that affects only about 27,000 people. Allergan wanted doctors to prescribe Botox for headaches. Botox's sales grew 1,407% and by 2007, total Botox sales exceeded $500 million. More than 70% of that was for unapproved uses.
This didn't seem to enter into the FDA's review of Allergan's application to expand its marketing of the Lap-Band, a device that's surgically implanted around the stomach. So far, the approved use has been for morbidly obese people. An FDA advisory panel, which gave preliminary approval to Allergan's application, wasn't entirely happy with the company's data supporting its safety and efficacy claims for the Lap-Band— its own 149-patient study and six other studies, at least three of which conducted by researchers with financial links to Allergan — but they felt that the Lap-Band's benefits outweighed the risks.
(HILTZIKLOS, M., Adapted from Los Angeles Times, 22/02/2011)
According to the text, it is correct to affirm that
 

Provas

Questão presente nas seguintes provas

Leia o Texto, abaixo, um trecho do capítulo CXXXVIII do romance Quincas Borba, de Machado de Assis, para responder à questão.

Repito, Sofia comia bem, dormia largo e fofo. Chegara ao fim da missão das Alagoas, com elogios da imprensa; a Atalaia chamou-lhe “o anjo da consolação”. E não se pense que este nome a alegrou, posto que a lisonjeasse; ao contrário, resumindo em Sofia toda a ação da caridade, podia mortificar novas amigas, e fazer-lhe perder em um dia o trabalho de longos meses. Assim se explica o artigo que a mesma folha trouxe no número seguinte, nomeando, particularizando e glorificando as outras comissárias – “estrelas de primeira grandeza”.

Nem todas as relações subsistiram, mas a maior parte delas estavam atadas, e não faltava à nossa dona o talento de as tornar definitivas. O marido é que pecava por turbulento, excessivo, derramado, dando bem a ver que o cumulavam de favores, que recebia finezas inesperadas e quase imerecidas. Sofia, para emendá-lo, vexava-o com censuras e conselhos, rindo:

– Você esteve hoje insuportável; parecia um criado.

Sofia é que, em verdade, corrigia tudo. Observava, imitava. Necessidade e vocação fizeram-lhe adquirir, aos poucos, o que não trouxera do nascimento nem da fortuna. Cortou as relações antigas, familiares, algumas tão íntimas que dificilmente se poderiam dissolver; mas a arte de receber sem calor, ouvir sem interesse e despedir-se sem pesar, não era das suas menores prendas; e uma por uma se foram indo as pobres criaturas modestas, sem maneiras, nem vestidos, amizades de pequena monta, de pagodes caseiros, de hábitos singelos e sem elevação.

ASSIS, Machado de. Obra Completa. Rio de Janeiro: Editora José Aguilar, 1962. p.759. Adaptado.

Levando em consideração o texto como um todo, assinale a alternativa correta.

 

Provas

Questão presente nas seguintes provas

Leia o Texto, abaixo, um trecho do capítulo CXXXVIII do romance Quincas Borba, de Machado de Assis, para responder à questão.

Repito, Sofia comia bem, dormia largo e fofo. Chegara ao fim da missão das Alagoas, com elogios da imprensa; a Atalaia chamou-lhe “o anjo da consolação”. E não se pense que este nome a alegrou, posto que a lisonjeasse; ao contrário, resumindo em Sofia toda a ação da caridade, podia mortificar novas amigas, e fazer-lhe perder em um dia o trabalho de longos meses. Assim se explica o artigo que a mesma folha trouxe no número seguinte, nomeando, particularizando e glorificando as outras comissárias – “estrelas de primeira grandeza”.

Nem todas as relações subsistiram, mas a maior parte delas estavam atadas, e não faltava à nossa dona o talento de as tornar definitivas. O marido é que pecava por turbulento, excessivo, derramado, dando bem a ver que o cumulavam de favores, que recebia finezas inesperadas e quase imerecidas. Sofia, para emendá-lo, vexava-o com censuras e conselhos, rindo:

– Você esteve hoje insuportável; parecia um criado.

Sofia é que, em verdade, corrigia tudo. Observava, imitava. Necessidade e vocação fizeram-lhe adquirir, aos poucos, o que não trouxera do nascimento nem da fortuna. Cortou as relações antigas, familiares, algumas tão íntimas que dificilmente se poderiam dissolver; mas a arte de receber sem calor, ouvir sem interesse e despedir-se sem pesar, não era das suas menores prendas; e uma por uma se foram indo as pobres criaturas modestas, sem maneiras, nem vestidos, amizades de pequena monta, de pagodes caseiros, de hábitos singelos e sem elevação.

ASSIS, Machado de. Obra Completa. Rio de Janeiro: Editora José Aguilar, 1962. p.759. Adaptado.

Levando em consideração o texto como um todo e as orientações da prescrição gramatical no que se refere a textos escritos na modalidade padrão da Língua Portuguesa, assinale a alternativa correta referente a trechos do quarto parágrafo.

 

Provas

Questão presente nas seguintes provas

Leia o Texto, abaixo, um trecho do capítulo CXXXVIII do romance Quincas Borba, de Machado de Assis, para responder à questão.

Repito, Sofia comia bem, dormia largo e fofo. Chegara ao fim da missão das Alagoas, com elogios da imprensa; a Atalaia chamou-lhe “o anjo da consolação”. E não se pense que este nome a alegrou, posto que a lisonjeasse; ao contrário, resumindo em Sofia toda a ação da caridade, podia mortificar novas amigas, e fazer-lhe perder em um dia o trabalho de longos meses. Assim se explica o artigo que a mesma folha trouxe no número seguinte, nomeando, particularizando e glorificando as outras comissárias – “estrelas de primeira grandeza”.

Nem todas as relações subsistiram, mas a maior parte delas estavam atadas, e não faltava à nossa dona o talento de as tornar definitivas. O marido é que pecava por turbulento, excessivo, derramado, dando bem a ver que o cumulavam de favores, que recebia finezas inesperadas e quase imerecidas. Sofia, para emendá-lo, vexava-o com censuras e conselhos, rindo:

– Você esteve hoje insuportável; parecia um criado.

Sofia é que, em verdade, corrigia tudo. Observava, imitava. Necessidade e vocação fizeram-lhe adquirir, aos poucos, o que não trouxera do nascimento nem da fortuna. Cortou as relações antigas, familiares, algumas tão íntimas que dificilmente se poderiam dissolver; mas a arte de receber sem calor, ouvir sem interesse e despedir-se sem pesar, não era das suas menores prendas; e uma por uma se foram indo as pobres criaturas modestas, sem maneiras, nem vestidos, amizades de pequena monta, de pagodes caseiros, de hábitos singelos e sem elevação.

ASSIS, Machado de. Obra Completa. Rio de Janeiro: Editora José Aguilar, 1962. p.759. Adaptado.

Levando em consideração o texto como um todo e as orientações da prescrição gramatical, no que se refere a textos escritos na modalidade padrão da Língua Portuguesa, assinale a alternativa correta referente a trechos do segundo parágrafo.

 

Provas

Questão presente nas seguintes provas